[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gastrointestinal-complication\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gastrointestinal-complication":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100521698","the-influence-of-feeding-source-on-the-gut-microbiome-and-time-to-full-feeds-in-neonates-with-congenital-gastrointestinal-pathologies-100521698",false,"NCT06072976","The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies","Inclusion Criteria:\n\n* Infants with gastroschisis, giant omphalocele, intestinal atresia, mid-gut volvulus, hirschsprungs disease.\n\nExclusion Criteria:\n\n1. Infant has already been on feeds\n2. Infants \\\u003C34 weeks gestation\n3. Parents with contraindications to providing milk (i.e. drug use-cocaine, fentanyl, meth BUT oxy\u002Fsuboxone\u002Fmarijuana OK)\n4. Complicated gastroschisis\n5. Short gut syndrome\n6. Additional congenital anomalies that affect ability to tolerate milk (i.e. cyanotic congenital heart disease BUT kidney disease ok)","ALL","0 Days","55 Years",{"count":19,"type":20},116,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.",[26,27,28,29,30,31],"Gastrointestinal Complication","Intestinal Obstruction","Gastroschisis","Hirschsprung Disease","Omphalocele","Midgut Volvulus","RECRUITING","2026-04-28",{"date":35,"type":36},"2026-04-30","ACTUAL",{"date":38,"type":36},"2023-06-09",{"date":40,"type":20},"2027-06-09",{"name":42,"class":43},"Seattle Children's Hospital","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":15,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":5},"100350911","collection-and-distribution-of-biospecimens-for-novel-research-uses-100350911","NCT03848962","Collection and Distribution of Biospecimens for Novel Research Uses","iSpecimen Network Protocol: Collection and Distribution of Remnant and Research Use Only Biospecimens for Novel Research Uses","Inclusion Criteria:\n\n* Individual is developmentally aged 7 years old and above for RUO collections (only)\n* Individual meets requirements of a current request for research materials from iSpecimen\n* If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and\u002For the review of an updated medical history as provided by the participant\n* Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent\u002Fguardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf.\n* Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent\u002Fguardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf\n\nExclusion Criteria:\n\n* Subjects that do not meet the inclusion criteria outlined above.",true,"1 Month","89 Years",{"count":56,"type":20},10000,"OBSERVATIONAL","iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations (\"institutions\") capable of providing researchers and educators (\"researchers\") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively \"research\").",[60,61,26,62,63,64,65,66],"Cancer","Healthy","Autoimmune Diseases","Infectious Disease","Women's Health: High-Risk Pregnancy","Dermatologic Disease","Blood Disease","2022-11-08",{"date":69,"type":36},"2022-11-09",{"date":71,"type":36},"2016-06-30",{"date":73,"type":20},"2026-12-31",{"name":75,"class":76},"iSpecimen Inc","INDUSTRY"]